 | Up a level |
Duckworth, CA 
ORCID: 0000-0001-9992-7540, Pritchard, David Mark ORCID: 0000-0001-7971-3561, Mihailuk, K, Simms, C, Reay, M, Madureira, P, Howarth, A, Murray, P, Nasser, S, Pilkington, GJ et al (show 1 more authors)
(2019)
IP1867B suppresses the insulin-like growth factor 1 receptor (IGF1R) ablating epidermal growth factor receptor inhibitor resistance in adult high grade gliomas.
Cancer Letters, 458.
pp. 29-38.
Halamoda-Kenzaoui, B, Vandebriel, RJ, Howarth, A ORCID: 0000-0003-2288-1745, Siccardi, M ORCID: 0000-0002-3539-7867, David, CAW ORCID: 0000-0001-8504-2354, Liptrott, NJ ORCID: 0000-0002-5980-8966, Santin, M, Borgos, SE, Bremer-Hoffmann, S and Caputo, F
(2021)
Methodological needs in the quality and safety characterisation of nanotechnology-based health products: Priorities for method development and standardisation.
JOURNAL OF CONTROLLED RELEASE, 336.
pp. 192-206.